Applied Biology
17780 Fitch
Irvine
California
92614
United States
Tel: 949-387-4526
Fax: 650-649-1962
Website: http://appliedbiology.com/
About Applied Biology
Applied Biology, headquartered in Irvine, California, is a biopharmaceutical company paving the way to radically new therapies in dermatology. Our research spans novel compounds ushering a paradigm shift in phototherapy to transformation of microbial organisms to deliver dermatological therapy.Founded by industry luminaries Prof. Andy Goren, Prof Torello Lotti, and Daniel Hafid in collaboration with world renowned dermatologists Dr. Jerry Shapiro, Dr. Jana Hercogova, and Dr. Robert Schwartz, Applied Biology is poised to brighten the future of dermatology patients.
LEADERSHIP:
Founders: Andy Goren, Prof Torello Lotti, and Daniel Hafid
CLINICAL TRIAL:
Please click here for clinical trial information.
10 articles with Applied Biology
-
Jupiter Wellness Acquires the Assets of Applied Biology Inc., a Leading Biotechnology Company Specializing in Hair and Skin Science
6/21/2022
Jupiter Wellness , Inc. (Nasdaq: JUPW ) today announced the acquisition of 100% of the assets of Applied Biology, Inc.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 23, 2020.
-
Applied Biology and Corpometria Institute Receive National IRB Approval to Study a Potential Breakthrough Therapy for COVID-19
9/22/2020
While studying the genetics of the androgen receptor, a team of scientists discovered a possible breakthrough treatment for COVID-19. The team led by Andy Goren, MD from Applied Biology, Flavio A. Cadegiani, MD, MSc, PhD from Corpometria Institute in Brazil, along with other collaborators, have published their discovery in several medical journ
-
Applied Biology and Kintor to Collaborate on the use of Proxalutamide for the Treatment of COVID-19
7/14/2020
While studying the effects of androgens on hair loss, Applied Biology scientists discovered an association between cellular receptors that predispose an individual to develop common hair loss (androgenetic alopecia) and COVID-19.
-
Applied Biology, in Collaboration With Brown University Researchers and Corpometria Institute, to Launch Anti-Androgen Clinical Study for the Treatment of COVID-19 (ANDROCOV TRIAL)
6/25/2020
While studying the genetics of the androgen receptor in male pattern baldness, a team of scientists discovered a possible breakthrough treatment for COVID-19.
-
Applied Biology to License Intellectual Property Rights to a Novel Cannabinoid Based Therapy Under Development for COVID-19
4/13/2020
Applied Biology, Inc. ("Applied Biology") announced today it has licensed to Applied Botanics, LLC. (Louisville, KY) intellectual property rights to a novel cannabinoid based therapy under development for COVID-19 and other respiratory illnesses.
-
Applied Biology to Launch New Molecular Diagnostic Laboratory for Hair and Skin Disorders
2/13/2020
APPLIED BIOLOGY TO INAUGURATE A NEW CLINICAL LABORATORY IN A BID TO PROVIDE DOCTORS AND PATIENTS WITH ACCESS TO BREAKTHROUGH RESEARCH IN HAIR AND SKIN SCIENCE
-
Applied Biology to Enter into a License Agreement with Hairmore for its Novel Treatment for Traction Alopecia
2/12/2019
Applied Biology's Novel Taar Receptor Agonist To Help Millions Of Chinese Women Suffering From Ponytail Induced Alopecia
-
Applied Biology Appoints Leonard Brandt as Chairman of the Board of Directors
1/22/2019
APPLIED BIOLOGY TO EXPAND ITS LEADERSHIP TEAM IN A BID TO COMMERCIALIZE ITS INNOVATIVE AESTHETICS PRODUCT PIPELINE
-
Daniel Alain Life Science Acquires Intellectual Property Rights From Applied Biology
8/10/2016